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Heme oxygenase-1 (HO-1) has been strongly highlighted because of its induction in many cell types by toxic stimuli, including oxidative
stress. The intense HO-1 immunostaining in the substantia nigra of Parkinson disease (PD) patients suggests its involvement in the pathogenesis of
this neurodegenerative disease. In this work we investigated HO-1 expression in rat substantia nigra postnatal cell cultures under conditions
mimicking dopamine toxicity and its modulation by glial cell line-derived neurotrophic factor (GDNF), a potent neuroprotective factor for
dopaminergic neurons. In neuron–glia cultures, we found that H2O2, a product of dopamine metabolism, or l-3,4-dihydroxyphenylalanine (l-
DOPA), the dopamine precursor used in the therapy of PD, induced a fast up-regulation of HO-1 mRNA and protein levels, followed by a
secondary down-regulation. H2O2 and l-DOPA also increased HO-1 expression in astrocyte cultures, but with a delayed time course in H2O2-
treated cultures. HO-1 expression was decreased in neuron–glia cultures under conditions under which GDNF up-regulation was observed.
Because exogenously applied GDNF prevented HO-1 up-regulation in cultures treated with H2O2 or l-DOPA, and antibody neutralization of
GDNF prevented the secondary HO-1 down-regulation observed in neuron–glia cultures, we propose that GDNF negatively modulates HO-1
expression induced by oxidative stress. To our knowledge, this is the first report showing the modulation of HO-1 expression by GDNF.
D 2005 Elsevier Inc. All rights reserved.Keywords: Astrocytes; Dopaminergic neurons; Glial cell line-derived neurotrophic factor; Heme oxygenase-1; Oxidative stress; Parkinson disease; Free radicalsUp-regulation of stress proteins is a universal response to
adverse conditions, and its protective role against a number of
insults has been established [1–3]. Heme-oxygenase-1 (HO-1),
also known as heat-shock protein 32 (HSP32) because of the
heat shock element in the promoter of its gene [4], is a small
stress protein with enzymatic activity involved in heme
catabolism, leading to the generation of biliverdin, free iron,
and CO. Three isoforms of HO, products of individual genes,
have been identified: the inducible HO-1 and the constitutive
HO-2 and HO-3 [5]. In the rat brain HO-1 is poorly expressed,
but it is quick and highly induced by various stress-associated
agents [6–8]. In the central nervous system, the HO pathway
has been shown to act as a fundamental defensive mechanism
for neurons exposed to an oxidant challenge [9–11].0891-5849/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.freeradbiomed.2005.08.005
Abbreviations: GDNF, glial cell line-derived neurotrophic factor; HO-1,
heme oxygenase-1; HSP, heat shock protein; l-DOPA, l-3,4-dihydroxyphe-
nylalanine; PD, Parkinson disease; ROS, reactive oxygen species.
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E-mail address: epduarte@cnc.cj.uc.pt (E.P. Duarte).The etiology of Parkinson disease (PD), a movement
disorder characterized by the selective loss of dopaminergic
neurons in the substantia nigra pars compacta, is currently
believed to involve the formation of dopamine-derived reactive
oxygen species (ROS), by both chemical and enzymatic
mechanisms, which can act as endogenous toxins if not
handled properly [12]. The involvement of HO-1 in the
pathogenesis of PD was suggested by the intense HO-1
immunostaining in the periphery of the Lewy bodies and a
significant increase in the fraction of astrocytes expressing HO-
1 in the substantia nigra of PD patients [13]. Furthermore, a
relatively rapid and persistent increase in HO-1 mRNA in
striatal astrocytes has been reported in the 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine mouse model of PD [14]. Moreover,
studies by Yoo et al. [15] showed a dramatic up-regulation of
HO-1 by oxidative stress in a dopaminergic cell line.
Neurotrophic factors are also up-regulated in response to
stressful conditions [16]. We have been investigating the effects
of selective injury to dopaminergic neurons on the expression of
glial cell line-derived neurotrophic factor (GDNF) in substantiaedicine 39 (2005) 1611 – 1619
www.elsevier.com/locate
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ability to promote the survival and branching of dopaminergic
neurons in culture [17]. In animal models of PD, GDNF was
shown to protect nigral dopaminergic neurons against injury, to
rescue them after toxin-induced injury, and to promote recovery
from motor deficits [18]. Moreover, the delivery of GDNF to
posterior putamen was shown to ameliorate PD symptoms in
human patients [19]. It was demonstrated, both in cell culture
models and in vivo, that protection of dopaminergic neurons by
GDNF involves up-regulation of antioxidant enzymes and
induction of antiapoptotic proteins [20,21].
Several reports uncovered a relationship between neuro-
trophic factors and the expression of stress proteins. Nerve
growth factor was shown to protect PC12 cells against ROS by
a mechanism involving the induction of HO-1 [22]. HO-1 is
also induced by fibroblast growth factor-1 in spinal cord
astrocytes [23]. In a model of ischemia/hypoxia-induced brain
injury, GDNF was shown to significantly reduce HSP70
induction [24,25]. After spinal cord injury, up-regulation of
HSP72 was considerably reduced in brain-derived neurotrophic
factor- (BDNF) or insulin like growth factor-1-pretreated rats
[26]. BDNF was also shown to suppress the expression of
HSP27 in rat retinal ganglion cells after axotomy [27].
In the present work we examined the effects of conditions
mimicking dopamine toxicity on the expression of HO-1 in
substantia nigra postnatal cell cultures and its relationship to
GDNF expression. Our results show that after an initial up-
regulation induced by the oxidant stimuli, HO-1 is down-
regulated in a process likely involving GDNF. To our
knowledge, this report is the first showing modulation of
HO-1 expression by GDNF. These data have been previously
reported in an abstract form [28].
Material and methods
Cell culture
Animals were handled in accordance with the national
ethical requirements for animal research and with the European
Convention for the Protection of Vertebrate Animals Used for
Experimental and Other Scientific Purposes. Postnatal sub-
stantia nigra neuron–glia cocultures were prepared as previ-
ously described by Burke et al. [29] with some modifications.
A coronal slice at the level of midbrain flexure was dissected
from postnatal day 1–3 Wistar rat pups, followed by the
dissection of the ventral segment of the midbrain (astrocyte
preparation) or the substantia nigra (neuronal preparation). The
tissue was then enzymatically dissociated under continuous
oxygenation using 20 U/ml papain (Roche) in 1 mM cysteine,
116 mM NaCl, 5.4 mM KCl, 26 mM NaHCO3, 2 mM
NaH2PO4, 1 mM MgSO4, 500 AM EDTA, 25 mM glucose, and
0.001% phenol red, at pH 7.3, for about 30 min at 33-C. To
stop digestion, tissue chunks were washed with culture
medium. The tissue was then mechanically dissociated and
the cell suspension pelleted, resuspended, and plated onto poly-
d-lysine- and laminin-coated coverslips under 0.8-cm2 holes in
the bottom of 50-mm snap-top polystyrene petri dishes (BDFalcon). For midbrain astrocyte cultures, 75,000 cells were
plated and fed with astrocyte culture medium M10C-G
(composition described in [29]). Once the cells were confluent,
25 AM 5-fluorodeoxyuridine with 70 AM uridine (FDU) was
added to the culture medium to suppress cell growth. The
neuronal cultures were established by plating 80,000 cells onto
confluent monolayers of midbrain astrocytes. Three days
before the neuronal cell preparation, the astrocyte culture
medium was changed to neuronal culture medium SF1C
(composition described in [29]) to allow the conditioning by
astrocytes. Proliferation of nonneuronal cells was suppressed
by addition of FDU 1 day after plating. The cultures were kept
at 37-C in a 5% CO2, 95% air atmosphere. Substantia nigra
neuron–glia cocultures were used after 1 week in culture, and
astrocyte cultures were used after confluence was reached. The
day before cell treatments, the culture medium of either
neuron–glia cultures or astrocyte cultures was replaced by
serum-free SF1C.
Western blot
Both GDNF and HO-1 protein levels were determined by
Western blot analysis of samples obtained by cell homogeni-
zation in a lysis buffer containing 25 mM Tris, 2.5 mM
EDTA, 2.5 mM EGTA, 1% Triton X-100, 1 mM DTT, 1 mM
PMSF, and 25 Ag/ml leupeptin. Protein concentration was
determined using the Bradford method with bovine serum
albumin as standard. Usually 15–25 Ag protein was separated
by SDS–PAGE using a 12% resolving gel under reducing
conditions and electrotransferred onto polyvinylidene difluor-
ide membranes (Amersham Life Sciences). After being
blocked with 5% milk powder in TBS-T (0.5% Tween 20 in
a 20 mM Tris and 137 mM NaCl solution), for 60 min at
room temperature, the membranes were incubated overnight at
4-C with rabbit anti-HO-1 (1:1000; Stressgen) or rabbit anti-
GDNF (1:1000; Santa Cruz Biotechnology) primary anti-
bodies diluted in TBS-T containing 1% milk powder. To
control for protein loading, the membranes were probed with a
mouse anti-a-tubulin antibody (1:10,000; Sigma). After being
rinsed, blots were incubated for 60 min, at room temperature,
with an alkaline phosphatase-conjugated secondary antibody
(Amersham Life Sciences), diluted 1:20,000 in TBS-T
containing 1% milk powder. Protein bands were detected
using the Enhanced ChemiFluorescence system (Amersham
Life Sciences) and quantified by densitometric analysis using
the Quantity One software (Bio-Rad).
Total RNA extraction and reverse transcription
Total RNA was extracted from substantia nigra cell cultures
using the TRIzol reagent (Invitrogen) according to the
manufacturer’s protocol. The isolated RNA was dissolved in
20 Al diethylpyrocarbonate-treated water and stored at 80-C.
DNase I (Gibco BRL) was used to treat RNA samples to
remove any residual genomic DNA. Samples were incubated
for 15 min at room temperature with DNase I, which was then
inactivated by incubation at 65-C for 10 min. To assess RNA
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Agilent 2100 Bioanalyzer using a RNA NanoLabChip (RNA
6000 Nano Assay; Agilent Technologies). RNA integrity
numbers were greater than 7 in all analyzed samples.
Single-stranded cDNA was synthesized using TaqMan
reverse transcription reagents (Roche Molecular Systems) by
incubating total RNA (0.5 Ag of DNase-treated RNA) for 10
min at 25-C and 30 min at 48-C in a final volume of 25 Al.
Reaction was terminated by incubating for 5 min at 95-C. All
samples were stored at 20-C until analysis. From the
resultant cDNA sample, 5 Al was used in the real-time PCR.
For control purposes, nontemplate samples were subjected to
PCR amplification.
Real-time PCR
Real-time PCR was performed to monitor the expression of
HO-1 and of a housekeeping gene, the 18S ribosomal RNA
(TaqMan ribosomal RNA control reagents). The TaqMan
technology was used and the results were analyzed in a 7900
HT sequence detector system (Applied Biosystems). Primers
and the TaqMan probe were selected from GenBank (Acces-
sion No. NM_012580) and designed using the primer design




TAMRA. Specificity of the primers was confirmed by a
BLAST search. The amplification reaction mixture (25 Al)
contained 5 Al of the cDNA sample, TaqMan Universal PCR
Master Mix, 50 nM each primer, and 50 nM TaqMan probe.
The thermal cycling conditions included 10 min at 95-C,
proceeding with 40 cycles of 95-C for 15 s and 60-C for 1 min.
The size of the PCR product was determined in an Agilent
2100 bioanalyzer using a DNA 1000 LabChip Kit (AgilentFig. 1. Effects of H2O2 and l-DOPA on HO-1 protein levels in substantia nigra n
concentrations of H2O2 or l-DOPA. Protein extracts were prepared and separated
Stressgen), anti-GDNF (1:1000; Santa Cruz Biotechnology), and anti-a-tubulin (1:1
tubulin are shown. Quantification was performed by densitometric analysis. The r
stimuli. *p < 0.05, **p < 0.01 compared to control.Technologies). The HO-1 mRNA levels were normalized to
that of 18S ribosomal RNA and expressed relative to control
using the DDCt method.
GDNF neutralization using an antibody
Substantia nigra cell cultures were incubated for 24 h with
or without 100 AM H2O2 or 200 AM l-DOPA, in the presence
or absence of the anti-GDNF antibody (0.4 Ag/ml; Santa Cruz
Biotechnology). About 10 h later, the application of the
antibody was repeated to ensure that only residual GDNF
would be available to bind to its receptor. The cultures were
then processed for Western blot analysis of HO-1 levels as
described above.
Data analysis and statistics
Data are expressed as percentages of values obtained under
control conditions and are presented as means T SEM of at
least three experiments, performed in triplicate, in independent
cell cultures. Statistical analysis was performed using one-way
ANOVA followed by Dunnett’s or Bonferroni’s test. Values of
p < 0.05 were considered significant.
Results
Effects of H2O2 and l-DOPA on HO-1 expression in substantia
nigra neuron–glia cultures
Dopaminergic neurons are highly vulnerable to oxidative
stress injury because dopamine itself can undergo spontaneous
or enzymatic oxidation, producing H2O2, superoxide, and
dopamine quinone [12]. H2O2 can react with transition metals,
like iron, generating hydroxyl radicals. In order to investigate
the effects of oxidative injury on HO-1 expression ineuron–glia cultures. Cell cultures were incubated for 24 h with the indicated
by SDS–PAGE followed by immunoblot analysis using anti-HO-1 (1:1000;
0,000; Sigma) antibodies. Representative Western blots for HO-1, GDNF, and
esults are expressed as the percentages of control incubated in the absence of
Fig. 2. Effects of H2O2 and l-DOPA on HO-1 mRNA levels in substantia nigra
neuron–glia cocultures. Cells were incubated with 100 AM H2O2 or 200 AM l-
DOPA for up to 24 h and total RNAwas extracted. After DNase treatment, 0.5
Ag of RNA from each sample was reverse transcribed and analyzed by real-time
PCR for HO-1 and for a housekeeping gene, the 18S ribosomal RNA. HO-1
mRNA levels were normalized to those of 18S ribosomal RNA and expressed
relative to control using the DDC t method. *p < 0.05, **p < 0.01 compared to
control.
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different concentrations of either H2O2 or l-DOPA, the
dopamine precursor used as a replacement therapy for PD
and also believed to increase oxidative stress. Surprisingly,
HO-1 protein levels decreased with increasing H2O2 concen-
trations: HO-1 levels decreased to 84.92 T 5.06 of control in
cultures exposed to 50 AM H2O2 and to 84.97 T 5.66% in
cultures exposed to 150 AM H2O2 (Fig. 1). In contrast,
exposure to l-DOPA increased HO-1 levels but revealed a
very unusual concentration-dependent relationship. Incubation
with 50 or 400 AM l-DOPA up-regulated HO-1 levels,
whereas 200 AM significantly reduced HO-1 levels to 79.79 T
3.04% of control (Fig. 1).Fig. 3. Time course of H2O2 and l-DOPA effects on HO-1 and GDNF protein levels
AM l-DOPA for the indicated periods of time. Protein extracts were prepared and
(1:1000; Santa Cruz Biotechnology) antibodies. Representative Western blots for H
was done by densitometric analysis. *p < 0.05, **p < 0.01, and ***p < 0.001 comH2O2 has been shown to induce HO-1 expression in many
systems [2,11,30], and the promoter of the HO-1 gene has
binding sequences for oxidative stress-responsive transcription
factors [31]. To clarify the unexpected effects of H2O2 and l-
DOPA on HO-1 expression, we examined the time course of
HO-1 mRNA and protein expression in substantia nigra
cultures exposed up to 24 h to H2O2 or l-DOPA. HO-1
mRNA levels were determined by real-time PCR. Cell
cultures treated with 100 AM H2O2 showed a fast increase
in HO-1 mRNA levels to 2.37 T 0.43-fold the control values
at 1 h, decreasing thereafter (Fig. 2). On the other hand, in
cultures incubated with 200 AM l-DOPA, the increase in HO-
1 mRNA levels was smaller (1.82 T 0.28-fold at 1 h), but
more sustained over time (1.74 T 0.28-fold the control levels
at 3 h) (Fig. 2).
Regarding the effects on HO-1 protein levels in neuron–glia
cultures (Fig. 3), we found an initial sustained increase
followed by a decrease to levels significantly below control
values after 24 h. HO-1 up-regulation caused by H2O2
exposure was less pronounced and more transient than that
elicited by l-DOPA. At 12 h, HO-1 levels in H2O2-treated
cultures were already decreasing, whereas in l-DOPA-treated
cultures they were maximal at this time point (182.04 T
11.64%). Despite the different temporal patterns of HO-1
expression in substantia nigra neuron–glia cocultures in
response to H2O2 and l-DOPA, HO-1 levels were down-
regulated at 24 h to about 80% of control in both cases. Fig. 3
also shows the changes in GDNF protein levels in the same
experiments. We observed a significant increase in GDNF
protein levels after 24 h in cultures treated with 100 AM H2O2
or 200 AM l-DOPA, coincidentally with a HO-1 down-
regulation. Similarly, in the concentration-response studies
(Fig. 1), HO-1 protein levels were decreased under conditions
under which GDNF up-regulation was observed.in neuron–glia cultures. The cultures were incubated with 100 AM H2O2 or 200
analyzed by immunoblot using anti-HO-1 (1:1000; Stressgen) and anti-GDNF
O-1 and GDNF cell content are shown. Quantification of the Western blot data
pared to control.
Fig. 4. Time course of H2O2 and l-DOPA effects on HO-1 protein levels in
midbrain astrocyte cultures. The cultures were incubated with 100 AM H2O2 or
200 AM l-DOPA for the indicated periods of time. Protein extracts were
prepared and separated by SDS–PAGE followed by immunoblot analysis using
an anti-HO-1 antibody (1:1000; Stressgen). Quantification was performed by
densitometric analysis. The results are expressed as the percentages of controls
incubated in the absence of stimuli. **p < 0.01 compared to control.
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We also investigated the effects of H2O2 and l-DOPA on
HO-1 levels in midbrain astrocyte cultures because stronger
HO-1 induction by oxidative stress has been reported in
astrocytes compared to neurons [30]. Moreover, we have found
that GDNF was not up-regulated in astrocyte cultures incubated
for 24 h with 100 AM H2O2 or 200 AM l-DOPA (unpublished
data), enabling us to examine HO-1 expression without theFig. 5. Effects of adding GDNF on HO-1 levels in (A) astrocyte and (B) neuron–gli
with H2O2 for 24 h or with l-DOPA for 12 h, in the presence or in the absence of 1
were incubated with 200 AM l-DOPA for 3, 6, or 12 h, in the presence or in the a
denatured GDNF (95-C for 10 min; dGDNF) was used. Protein extracts were then pr
***p < 0.001 compared to control; and ###p < 0.001 compared to 100 AM H2O2modulation by endogenous GDNF. Fig. 4 shows the time course
of the effects of 100 AM H2O2 or 200 AM l-DOPA on HO-1
levels in astrocyte cultures. In l-DOPA-treated cultures, HO-1
levels were elevated at all time points tested but the increases
were statistically significant only at 6 and 12 h. On the other
hand, incubation with H2O2 led to HO-1 up-regulation only at
24 h. Surprisingly, 3 h after addition of 100 AMH2O2, astrocyte
cultures consistently exhibited reduced HO-1 levels to 64.8 T
2.2% of control (Fig. 4). Interestingly, the temporal pattern of
HO-1 changes in H2O2-treated astrocytes was distinct from that
observed in neuron–glia cultures, in contrast to what was
observed in l-DOPA-treated cultures (Figs. 3 and 4), suggesting
that the mechanisms involved in HO-1 expression in response to
H2O2 and l-DOPA might be different.
The addition of GDNF prevented HO-1 up-regulation in
challenged cultures
The observation that HO-1 levels were decreased in
neuron–glia cultures under conditions under which GDNF
was up-regulated (Figs. 1 and 3) raised the hypothesis that
GDNF could be responsible for the down-regulation of HO-1.
To address this question we determined the effects of adding
GDNF on HO-1 levels in astrocyte cultures treated with H2O2
for 24 h or l-DOPA for 12 h. These incubation periods were
selected based on the maximal effect of H2O2 and l-DOPA on
HO-1 levels in astrocyte cultures (Fig. 4). In both H2O2- and l-
DOPA-treated cultures, the presence of 1 ng/ml GDNF
prevented HO-1 up-regulation, keeping HO-1 expression ata cultures challenged with H2O2 or l-DOPA. Astrocyte cultures were incubated
or 10 ng/ml recombinant human GDNF (R&D Systems). Neuron–glia cultures
bsence of 1 ng/ml recombinant human GDNF. To control for specificity, heat-
epared and processed for HO-1 immunoblotting. ns, not significant; **p < 0.01,
or 200 AM l-DOPA alone.
Fig. 6. Effects of GDNF neutralization during H2O2 or l-DOPA exposure on
HO-1 levels in neuron–glia cultures. Cell cultures were incubated for 24 h with
100 AM H2O2 or 200 AM l-DOPA in the presence (+) or the absence () of the
anti-GDNF antibody (0.4 Ag/ml; with reinforcement after approximately 10 h)
and processed for HO-1 immunoblotting. ***p < 0.001 compared to control
and ###p < 0.001 compared to the same condition in the absence of the anti-
GDNF antibody.
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160.3 T 5.9 to 96.3 T 8.6% in H2O2-treated cultures, and from
161.8 T 9.6 to 87.8 T 5.6% in l-DOPA-treated cultures. We
found no significant differences in the effects of 1 and 10 ng/
ml GDNF on HO-1 levels in H2O2 or l-DOPA-challenged
cultures, and neither 1 nor 10 ng/ml GDNF had significant
effects on HO-1 levels in control astrocyte cultures (Fig. 5A).
We also tested the effects of adding GDNF on HO-1
expression in neuron–glia cultures at time points before
significant GDNF up-regulation was observed (see Fig. 3).
As shown in Fig. 5B, the presence of native GDNF, but not of
heat-denatured GDNF (95-C for 10 min), prevented the
increase in HO-1 protein levels observed at 3, 6, and 12 h upon
treatment with 200 AM l-DOPA. Because heat-denatured
GDNF did not significantly affect HO-1 induction by l-DOPA
we can conclude that this is a specific effect.
Antibody neutralization of GDNF in substantia nigra
neuron–glia cultures prevented HO-1 down-regulation
To further investigate whether GDNF was controlling HO-1
expression, we determined the effects of GDNF neutralization
on HO-1 levels in neuron–glia cultures. Cells were incubated
for 24 h with 100 AM H2O2 or 200 AM l-DOPA in the
presence or in the absence of an anti-GDNF antibody (Fig. 6).
GDNF neutralization prevented HO-1 down-regulation at 24
h both in H2O2- and in l-DOPA-treated cultures, increasing
HO-1 levels from 80.31 T 3.86 to 120.70 T 2.54% and from
80.44 T 4.33 to 134.40 T 0.32%, respectively. Moreover, in
control cells incubated with the anti-GDNF antibody, HO-1
was up-regulated to 123.31 T 2.82% of control levels,
suggesting that basal levels of GDNF were modulating HO-1
expression.
Discussion
In the present work we found that conditions mimicking
dopamine toxicity triggered a transient up-regulation of HO-1
expression in substantia nigra cell cultures, and we gatheredevidence showing that GDNF is involved in the secondary
down-regulation of HO-1. The catabolism of heme by HO
leads to the production of two potent antioxidants, biliverdin
and bilirubin ([32], reviewed in [5]), that are neuroprotective at
nanomolar concentrations [10]. Their antioxidant actions can
be explained by consecutive cycles of oxidation–reduction
between bilirubin and biliverdin [33]. In this context, the fast
up-regulation of HO-1 mRNA and protein levels observed in
substantia nigra cell cultures (Figs. 2 and 3) would provide a
way to protect cells against H2O2- and l-DOPA-induced
toxicity. Many studies support the importance of HO-1 in
protecting different cell types, including neurons, against
oxidative stress injury. Induction of HO-1 or low levels of
overexpression are associated with protection against oxidative
stress [9,11,22,30,34–36]. Moreover, HO-1 preinduction in
different injury models confers increased resistance to oxida-
tive stress [2,37–39]. On the other hand, suppressing HO
activity using antisense transfection [37,40] or inhibitors
[40,41] worsened oxidative stress. However, high levels of
HO-1 expression may be toxic due to excessive cellular levels
of heme-derived free iron [42]. Because the levels of HO-1 up-
regulation upon H2O2 or l-DOPA exposure were in the low
overexpression range (Figs. 1, 3, and 4) we can assume that
HO-1 conferred protection against oxidative stress-induced
damage. Expression of HO-1 in glia has been described in
different models of brain injury [6,43–45]. H2O2 has been
shown to induce HO-1 expression [11,46–48], and studies
from Fauconneau et al. [2] and Chen et al. [9] support a role for
glial HO-1 in the protection against H2O2-mediated oxidative
stress.
The induction of HO-1 was also shown to be coupled to the
induction of ferritin, which safely sequesters the iron released
during heme degradation, thus avoiding its participation in the
Fenton reaction and the generation of several free radical
species [37,42,49–51]. The expression of HO-1 was also
linked to the cellular efflux of iron [52], and HO-1 expression
up-regulates an iron ATPase present in the endoplasmic
reticulum, decreasing iron intracellular content [53].
Although both H2O2 and l-DOPA are expected to increase
oxidative stress, we observed significant differences in the
expression patterns of HO-1 induced by these two stimuli. l-
DOPA triggered fast and sustained increases in HO-1 protein
levels in both neuron–glia and astrocyte cultures, whereas
H2O2 induction of HO-1 was higher in mixed cultures,
compared to the greatly delayed induction in astrocyte
cultures (Figs. 3 and 4). These differences suggest partially
distinct mechanisms of HO-1 induction by H2O2 or l-DOPA,
and dopamine derived from l-DOPA may be involved.
Exogenous dopamine was shown to increase HO-1 mRNA
levels in cultured astrocytes and in C6 glioma cells [45,54]. It
was also suggested that dopaminergic terminals could produce
substances that directly or indirectly induce HO-1 in adjacent
astrocytes and that dopamine itself, or a dopamine metabolite,
could be the endogenous agent triggering HO-1 expression in
astrocytes [14]. It should be noted that astrocytes are capable
of transporting l-DOPA and decarboxylating it to dopamine
[55].
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increases in HO-1 levels in mixed cultures than in astrocyte
cultures (Figs. 2 and 4). Astrocytes were shown to have more
glutathione peroxidase and catalase activities and a corre-
spondingly greater capacity to metabolize H2O2 than neurons
[56–58]. This ability can explain the small induction of HO-1
in astrocyte cultures (Fig. 4). On the other hand, in neuron–glia
mixed cultures, incubation with H2O2 could decrease dopamine
uptake, because oxidative stress has been shown to inhibit
dopamine transport in striatal synaptosomes, thus leading to
extracellular accumulation of dopamine [59]. This would in
turn induce HO-1 in astrocytes [45], accounting for the higher
HO-1 levels in neuron–glia mixed cultures compared to
astrocyte cultures.
The down-regulation of HO-1 protein observed at longer
time points (Fig. 3) could be the consequence of its own up-
regulation in response to H2O2 or l-DOPA because Chen et al.
[9] have demonstrated that increased levels of HO-1 are
associated with a decrease in the accumulation and/or formation
of oxygen radicals. Furthermore, Suttner and Dennery [42]
have shown that, at low levels of HO-1 expression, protein
carbonyl content and lipid peroxide by-products were visibly
decreased compared to controls. Moreover, previous HO-1 up-
regulation was shown to induce the MnSOD gene in rat
astroglia cultures exposed to dopamine [60].
However, our data point to another player in the negative
modulation of HO-1 expression. Several lines of evidence in the
present work suggest that GDNF is involved in the down-
regulation of HO-1: (i) the dependence of HO-1 expression on
l-DOPA concentration was opposite to that of GDNF expres-
sion upon l-DOPA treatment (Fig. 1), (ii) there was a temporal
correlation between HO-1 down-regulation and GDNF up-
regulation (Fig. 3), (iii) the addition of exogenous GDNF
prevented HO-1 up-regulation in astrocyte and in neuron–glia
cultures treated with H2O2 or l-DOPA (Fig. 5), and (iv)
antibody neutralization of GDNF in neuron–glia mixed cultures
prevented HO-1 down-regulation at 24 h (Fig. 6).
The down-regulation of HO-1 by GDNF can be mediated by
a decrease in oxidative stress levels, because GDNF was shown
to suppress the accumulation of oxygen radicals induced by
bleomycin sulfate in mesencephalic cultures [20] or by kainate
in hippocampus [61] and to significantly elevate the activities
of superoxide dismutase, catalase, and glutathione peroxidase
[21,61]. Another hypothesis is that GDNF may be modulating
HO-1 expression at the transcriptional level, as was suggested
for other growth factors [22,23,62,63]. The promoter of the
HO-1 gene contains a complex set of regulatory elements [64],
some of them targets for transcription factors potentially
regulated by the PI3K/Akt pathway, a GDNF signaling
pathway [65]. GDNF also induces the transcription factor
murine GDNF-inducible factor, which negatively regulates
transcription [66].
In conclusion, we propose that cells exposed to conditions
mimicking dopamine toxicity up-regulate HO-1 in response to
increased oxidative stress, as a protective strategy. In a second
phase, GDNF, also up-regulated in response to injury, would
down-regulate HO-1, keeping its expression at a protectivelevel. To our knowledge, this is the first report showing
modulation of HO-1 by GDNF, with potential relevance to PD.
The lower levels of GDNF reported in the substantia nigra of
PD patients [67] may contribute to the increased HO-1 levels
observed in this brain region, where a significant increase in
the fraction of astrocytes expressing HO-1 has been reported
and neurons exhibit intense HO-1 immunostaining in the
periphery of the Lewy bodies ([13], reviewed in [5]). The up-
regulation of HO-1 in response to conditions of oxidative stress
would then become overwhelming, and the release of iron from
heme degradation by HO-1 would exacerbate oxidative injury
to dopaminergic neurons.Acknowledgments
We are grateful to Dr. David Sulzer (Columbia University,
New York, NY, USA) for his help in establishing the postnatal
cell culture model used in this work, and to Dr. Paulo Santos
(Center for Histocompatibility, Coimbra, Portugal) for his
assistance in the real-time PCR experiments. This work was
supported by the Bissaya Barreto Foundation and the Founda-
tion for Science and Technology, Portugal (Grant SFRH/BD/
5337/2001 to Ana Saavedra).References
[1] Calabrese, V.; Lodi, R.; Tonon, C.; D’Agata, V.; Sapienza, M.;
Scapagnini, G.; Mangiameli, A.; Pennisi, G.; Stella, A. M.; Butter-
field, D. A. Oxidative stress, mitochondrial dysfunction and cellular
stress response in Friedreich’s ataxia. J. Neurol. Sci. 233:145–162;
2005.
[2] Fauconneau, B.; Petegnief, V.; Sanfeliu, C.; Piriou, A.; Planas, A. M.
Induction of heat shock proteins (HSPs) by sodium arsenite in
cultured astrocytes and reduction of hydrogen peroxide-induced cell
death. J. Neurochem. 83:1338–1348; 2002.
[3] Kelly, S.; Yenari, M. A. Neuroprotection: heat shock proteins. Curr.
Med. Res. Opin. 18(Suppl. 2):s55–s60; 2002.
[4] Shibahara, S.; Muller, R. M.; Taguchi, H. Transcriptional control of rat
heme oxygenase by heat shock. J. Biol. Chem. 262:12889–12892; 1987.
[5] Schipper, H. M. Heme oxygenase expression in human central nervous
system disorders. Free Radic. Biol. Med. 37:1995–2011; 2004.
[6] Geddes, J. W.; Pettigrew, L. C.; Holtz, M. L.; Craddock, S. D.; Maines,
M. D. Permanent focal and transient global cerebral ischemia increase
glial and neuronal expression of heme oxygenase-1, but not heme
oxygenase-2, protein in rat brain. Neurosci. Lett. 210:205–208; 1996.
[7] Paschen, W.; Uto, A.; Djuricic, B.; Schmitt, J. Hemeoxygenase
expression after reversible ischemia of rat brain. Neurosci. Lett.
180:5–8; 1994.
[8] Scapagnini, G.; D’Agata, V.; Calabrese, V.; Pascale, A.; Colombrita, C.;
Alkon, D.; Cavallaro, S. Gene expression profiles of heme oxygenase
isoforms in the rat brain. Brain Res. 954:51–59; 2002.
[9] Chen, K.; Gunter, K.; Maines, M. D. Neurons overexpressing heme
oxygenase-1 resist oxidative stress-mediated cell death. J. Neurochem.
75:304–313; 2000.
[10] Dore, S.; Takahashi, M.; Ferris, C. D.; Zakhary, R.; Hester, L. D.;
Guastella, D.; Snyder, S. H. Bilirubin, formed by activation of heme
oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl.
Acad. Sci. USA 96:2445–2450; 1999.
[11] Le, W. D.; Xie, W. J.; Appel, S. H. Protective role of heme
oxygenase-1 in oxidative stress-induced neuronal injury. J. Neurosci.
Res. 56:652–658; 1999.
[12] Lotharius, J.; Brundin, P. Pathogenesis of Parkinson’s disease: dopa-
A. Saavedra et al. / Free Radical Biology & Medicine 39 (2005) 1611–16191618mine, vesicles and alpha-synuclein. Nat. Rev. Neurosci. 3:932–942;
2002.
[13] Schipper, H. M.; Liberman, A.; Stopa, E. G. Neural heme oxygenase-1
expression in idiopathic Parkinson’s disease. Exp. Neurol. 150:60–68;
1998.
[14] Fernandez-Gonzalez, A.; Perez-Otano, I.; Morgan, J. I. MPTP selective-
ly induces haem oxygenase-1 expression in striatal astrocytes. Eur. J.
Neurosci. 12:1573–1583; 2000.
[15] Yoo, M. S.; Chun, H. S.; Son, J. J.; DeGiorgio, L. A.; Kim, D. J.;
Peng, C.; Son, J. H. Oxidative stress regulated genes in nigral
dopaminergic neuronal cells: correlation with the known pathology
in Parkinson’s disease. Brain Res. Mol. Brain Res. 110:76–84;
2003.
[16] Martino, G. How the brain repairs itself: new therapeutic strategies in
inflammatory and degenerative CNS disorders. Lancet Neurol.
3:372–378; 2004.
[17] Lin, L. F.; Doherty, D. H.; Lile, J. D.; Bektesh, S.; Collins, F. GDNF: a
glial cell line-derived neurotrophic factor for midbrain dopaminergic
neurons. Science 260:1130–1132; 1993.
[18] Hurelbrink, C. B.; Barker, R. A. Prospects for the treatment of
Parkinson’s disease using neurotrophic factors. Expert Opin. Pharma-
cother. 2:1531–1543; 2001.
[19] Gill, S. S.; Patel, N. K.; Hotton, G. R.; O’Sullivan, K.; McCarter, R.;
Bunnage, M.; Brooks, D. J.; Svendsen, C. N.; Heywood, P. Direct brain
infusion of glial cell line-derived neurotrophic factor in Parkinson
disease. Nat. Med. 9:589–595; 2003.
[20] Sawada, H.; Ibi, M.; Kihara, T.; Urushitani, M.; Nakanishi, M.;
Akaike, A.; Shimohama, S. Neuroprotective mechanism of glial cell
line-derived neurotrophic factor in mesencephalic neurons. J. Neu-
rochem. 74:1175–1184; 2000.
[21] Chao, C. C.; Lee, E. H. Neuroprotective mechanism of glial cell line-
derived neurotrophic factor on dopamine neurons: role of antioxidation.
Neuropharmacology 38:913–916; 1999.
[22] Salinas, M.; Diaz, R.; Abraham, N. G.; Ruiz de Galarreta, C. M.;
Cuadrado, A. Nerve growth factor protects against 6-hydroxydopamine-
induced oxidative stress by increasing expression of heme oxygenase-1
in a phosphatidylinositol 3-kinase-dependent manner. J. Biol. Chem.
278:13898–13904; 2003.
[23] Vargas, M. R.; Pehar, M.; Cassina, P.; Martinez-Palma, L.; Thompson,
J. A.; Beckman, J. S.; Barbeito, L. Fibroblast growth factor-1 induces
heme oxygenase-1 via nuclear factor erythroid 2-related factor 2 (Nrf2)
in spinal cord astrocytes: consequences for motor neuron survival.
J. Biol. Chem. 280:25571–25579; 2005.
[24] Abe, K.; Hayashi, T.; Itoyama, Y. Amelioration of brain edema by
topical application of glial cell line-derived neurotrophic factor in
reperfused rat brain. Neurosci. Lett. 231:37–40; 1997.
[25] Ikeda, T.; Xia, X. Y.; Xia, Y. X.; Ikenoue, T.; Han, B.; Choi, B. H. Glial
cell line-derived neurotrophic factor protects against ischemia/hypoxia-
induced brain injury in neonatal rat. Acta Neuropathol. (Berlin)
100:161–167; 2000.
[26] Sharma, H. S.; Nyberg, F.; Gordh, T.; Alm, P.; Westman, J. Neurotrophic
factors influence upregulation of constitutive isoform of heme oxygenase
and cellular stress response in the spinal cord following trauma: an
experimental study using immunohistochemistry in the rat. Amino Acids
19:351–361; 2000.
[27] Krueger-Naug, A. M.; Emsley, J. G.; Myers, T. L.; Currie, R. W.; Clarke,
D. B. Administration of brain-derived neurotrophic factor suppresses the
expression of heat shock protein 27 in rat retinal ganglion cells following
axotomy. Neuroscience 116:49–58; 2003.
[28] Saavedra, A.; Baltazar, G.; Carvalho, C. M.; Duarte, E. P. Heme
oxygenase-1 expression is modulated by glial cell-line derived neuro-
trophic factor in substantia nigra postnatal cell cultures. In: Abstract
viewer/itinerary planner, Program 50.6. Washington, DC: Society for
Neuroscience; 2004.
[29] Burke, R. E.; Antonelli, M.; Sulzer, D. Glial cell line-derived
neurotrophic growth factor inhibits apoptotic death of postnatal
substantia nigra dopamine neurons in primary culture. J. Neurochem.
71:517–525; 1998.[30] Dwyer, B. E.; Nishimura, R. N.; Lu, S. Y. Differential expression of
heme oxygenase-1 in cultured cortical neurons and astrocytes deter-
mined by the aid of a new heme oxygenase antibody: response to
oxidative stress. Brain Res. Mol. Brain Res. 30:37–47; 1995.
[31] Immenschuh, S.; Ramadori, G. Gene regulation of heme oxygenase-1 as
a therapeutic target. Biochem. Pharmacol. 60:1121–1128; 2000.
[32] Stocker, R.; Yamamoto, Y.; McDonagh, A. F.; Glazer, A. N.; Ames,
B. N. Bilirubin is an antioxidant of possible physiological importance.
Science 235:1043–1046; 1987.
[33] Sedlak, T. W.; Snyder, S. H. Bilirubin benefits: cellular protection by
a biliverdin reductase antioxidant cycle. Pediatrics 113:1776–1782;
2004.
[34] Clark, J. E.; Foresti, R.; Green, C. J.; Motterlini, R. Dynamics of haem
oxygenase-1 expression and bilirubin production in cellular protection
against oxidative stress. Biochem. J. 348(Pt 3):615–619; 2000.
[35] Panahian, N.; Yoshiura, M.; Maines, M. D. Overexpression of heme
oxygenase-1 is neuroprotective in a model of permanent middle cerebral
artery occlusion in transgenic mice. J. Neurochem. 72:1187–1203;
1999.
[36] Takizawa, S.; Hirabayashi, H.; Matsushima, K.; Tokuoka, K.; Shino-
hara, Y. Induction of heme oxygenase protein protects neurons in cortex
and striatum, but not in hippocampus, against transient forebrain
ischemia. J. Cereb. Blood Flow Metab. 18:559–569; 1998.
[37] Vile, G. F.; Basu-Modak, S.; Waltner, C.; Tyrrell, R. M. Heme oxygenase
1 mediates an adaptive response to oxidative stress in human skin
fibroblasts. Proc. Natl. Acad. Sci. USA 91:2607–2610; 1994.
[38] Yang, Y.; Ohta, K.; Shimizu, M.; Morimoto, K.; Goto, C.; Nakai, A.;
Toma, T.; Kasahara, Y.; Yachie, A.; Seki, H.; Koizumi, S. Selective
protection of renal tubular epithelial cells by heme oxygenase (HO)-1
during stress-induced injury. Kidney Int. 64:1302–1309; 2003.
[39] Yoneya, R.; Nagashima, Y.; Sakaki, K.; Hagiwara, K.; Teraoka, H.;
Ozasa, H.; Horikawa, S. Hemolysate pretreatment ameliorates ischemic
acute renal injury in rats. Nephron 92:407–413; 2002.
[40] Dennery, P. A.; Sridhar, K. J.; Lee, C. S.; Wong, H. E.; Shokoohi, V.;
Rodgers, P. A.; Spitz, D. R. Heme oxygenase-mediated resistance to
oxygen toxicity in hamster fibroblasts. J. Biol. Chem. 272:14937–14942;
1997.
[41] Otterbein, L.; Sylvester, S. L.; Choi, A. M. Hemoglobin provides
protection against lethal endotoxemia in rats: the role of heme
oxygenase-1. Am. J. Respir. Cell Mol. Biol. 13:595–601; 1995.
[42] Suttner, D. M.; Dennery, P. A. Reversal of HO-1 related cytoprotec-
tion with increased expression is due to reactive iron. FASEB J.
13:1800–1809; 1999.
[43] Fukuda, K.; Richmon, J. D.; Sato, M.; Sharp, F. R.; Panter, S. S.; Noble,
L. J. Induction of heme oxygenase-1 (HO-1) in glia after traumatic brain
injury. Brain Res. 736:68–75; 1996.
[44] Koistinaho, J.; Miettinen, S.; Keinanen, R.; Vartiainen, N.; Roivainen,
R.; Laitinen, J. T. Long-term induction of haem oxygenase-1 (HSP-32)
in astrocytes and microglia following transient focal brain ischaemia in
the rat. Eur. J. Neurosci. 8:2265–2272; 1996.
[45] Schipper, H. M.; Bernier, L.; Mehindate, K.; Frankel, D. Mitochondrial
iron sequestration in dopamine-challenged astroglia: role of heme
oxygenase-1 and the permeability transition pore. J. Neurochem.
72:1802–1811; 1999.
[46] Keyse, S. M.; Tyrrell, R. M. Heme oxygenase is the major 32-kDa stress
protein induced in human skin fibroblasts by UVA radiation, hydrogen
peroxide, and sodium arsenite. Proc. Natl. Acad. Sci. USA 86:99–103;
1989.
[47] Keyse, S. M.; Applegate, L. A.; Tromvoukis, Y.; Tyrrell, R. M. Oxidant
stress leads to transcriptional activation of the human heme oxygenase
gene in cultured skin fibroblasts. Mol. Cell Biol. 10:4967–4969; 1990.
[48] Lautier, D.; Luscher, P.; Tyrrell, R. M. Endogenous glutathione levels
modulate both constitutive and UVA radiation/hydrogen peroxide
inducible expression of the human heme oxygenase gene. Carcinoge-
nesis 13:227–232; 1992.
[49] Balla, G.; Jacob, H. S.; Balla, J.; Rosenberg, M.; Nath, K.; Apple, F.;
Eaton, J. W.; Vercellotti, G. M. Ferritin: a cytoprotective antioxidant
stratagem of endothelium. J. Biol. Chem. 267:18148–18153; 1992.
A. Saavedra et al. / Free Radical Biology & Medicine 39 (2005) 1611–1619 1619[50] Hill-Kapturczak, N.; Thamilselvan, V.; Liu, F.; Nick, H. S.; Agarwal,
A. Mechanism of heme oxygenase-1 gene induction by curcumin in
human renal proximal tubule cells. Am. J. Physiol. Renal Physiol.
281:F851–F859; 2001.
[51] Vile, G. F.; Tyrrell, R. M. Oxidative stress resulting from ultraviolet
A irradiation of human skin fibroblasts leads to a heme oxygenase-
dependent increase in ferritin. J. Biol. Chem. 268:14678–14681;
1993.
[52] Ferris, C. D.; Jaffrey, S. R.; Sawa, A.; Takahashi, M.; Brady, S. D.;
Barrow, R. K.; Tysoe, S. A.; Wolosker, H.; Baranano, D. E.; Dore, S.;
Poss, K. D.; Snyder, S. H. Haem oxygenase-1 prevents cell death by
regulating cellular iron. Nat. Cell Biol. 1:152–157; 1999.
[53] Baranano, D. E.; Wolosker, H.; Bae, B. I.; Barrow, R. K.; Snyder, S. H.;
Ferris, C. D. A mammalian iron ATPase induced by iron. J. Biol. Chem.
275:15166–15173; 2000.
[54] Schmidt, J.; Mertz, K.; Morgan, J. I. Regulation of heme oxygenase-1
expression by dopamine in cultured C6 glioma and primary astrocytes.
Brain Res. Mol. Brain Res. 73:50–59; 1999.
[55] Tsai, M. J.; Lee, E. H. Characterization of l-DOPA transport in cultured
rat and mouse astrocytes. J. Neurosci. Res. 43:490–495; 1996.
[56] Desagher, S.; Glowinski, J.; Premont, J. Astrocytes protect neurons from
hydrogen peroxide toxicity. J. Neurosci. 16:2553–2562; 1996.
[57] Dringen, R.; Kussmaul, L.; Gutterer, J. M.; Hirrlinger, J.; Hamprecht,
B. The glutathione system of peroxide detoxification is less efficient
in neurons than in astroglial cells. J. Neurochem. 72:2523–2530;
1999.
[58] Makar, T. K.; Nedergaard, M.; Preuss, A.; Gelbard, A. S.; Perumal, A. S.;
Cooper, A. J. Vitamin E, ascorbate, glutathione, glutathione disulfide,
and enzymes of glutathione metabolism in cultures of chick astrocytes
and neurons: evidence that astrocytes play an important role in
antioxidative processes in the brain. J. Neurochem. 62:45–53; 1994.[59] Berman, S. B.; Zigmond, M. J.; Hastings, T. G. Modification of
dopamine transporter function: effect of reactive oxygen species and
dopamine. J. Neurochem. 67:593–600; 1996.
[60] Frankel, D.; Mehindate, K.; Schipper, H. M. Role of heme
oxygenase-1 in the regulation of manganese superoxide dismutase
gene expression in oxidatively-challenged astroglia. J. Cell. Physiol.
185:80–86; 2000.
[61] Cheng, H.; Fu, Y. S.; Guo, J. W. Ability of GDNF to diminish free
radical production leads to protection against kainate-induced excito-
toxicity in hippocampus. Hippocampus 14:77–86; 2004.
[62] Durante, W.; Peyton, K. J.; Schafer, A. I. Platelet-derived growth factor
stimulates heme oxygenase-1 gene expression and carbon monoxide
production in vascular smooth muscle cells. Arterioscler. Thromb. Vasc.
Biol. 19:2666–2672; 1999.
[63] Kutty, R. K.; Nagineni, C. N.; Kutty, G.; Hooks, J. J.; Chader, G. J.;
Wiggert, B. Increased expression of heme oxygenase-1 in human retinal
pigment epithelial cells by transforming growth factor-beta. J. Cell.
Physiol. 159:371–378; 1994.
[64] Elbirt, K. K.; Bonkovsky, H. L. Heme oxygenase: recent advances in
understanding its regulation and role. Proc. Assoc. Am. Physicians
111:438–447; 1999.
[65] Airaksinen, M. S.; Saarma, M. The GDNF family: signalling,
biological functions and therapeutic value. Nat. Rev. Neurosci. 3:
383–394; 2002.
[66] Yajima, S.; Lammers, C. H.; Lee, S. H.; Hara, Y.; Mizuno, K.;
Mouradian, M. M. Cloning and characterization of murine glial
cell-derived neurotrophic factor inducible transcription factor
(MGIF). J. Neurosci. 17:8657–8666; 1997.
[67] Chauhan, N. B.; Siegel, G. J.; Lee, J. M. Depletion of glial cell line-
derived neurotrophic factor in substantia nigra neurons of Parkinson’s
disease brain. J. Chem. Neuroanat. 21:277–288; 2001.
